ACXP icon

Acurx Pharmaceuticals
ACXP

Overview Fund Activity

32 hedge funds and large institutions have $1.33M invested in Acurx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+8
Holders Change %
+33.33%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
8
Reduced
9
Closed
1
Calls
$33K
Puts
$29K
Net Calls
+$4K
Net Calls Change
-$1K

Top Buyers

1
AC
1
Armistice Capital
New York
$551K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$35.6K
3
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$43K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$44.8K
5
OBGC
5
O'Brien Greene & Co
Pennsylvania
$30.6K

Top Sellers

1
SM
1
Sabby Management
Florida
$41.8K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$74.4K
3
PFS
3
Prospect Financial Services
New York
$152K
4
SFA
4
Semmax Financial Advisors
North Carolina
$684
5
BlackRock
5
BlackRock
New York
$615
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
26
Simplex Trading
Illinois
$3K +$2.39K +274 +391%
TRCT
27
Tower Research Capital (TRC)
New York
$2.12K -$133 -13 -6%
CPG
28
Cornerstone Planning Group
New Jersey
$850 -$16.9K -159 -95%
Bank of America
29
Bank of America
North Carolina
$689 +$618 +61 +871%
SFA
30
Semmax Financial Advisors
North Carolina
$684 -$23.4K -274 -97%
BlackRock
31
BlackRock
New York
$615 -$16.9K -1,652 -96%
SS
32
SBI Securities
Japan
$145 – – –
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
– -$11 -1 Closed
1
2